This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Apollo, Juniper: New Targets, Estimates

Stocks in this article: APOL CVC

Also see: AMC, General Mills: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES

Apollo Group (APOL - Get Report) estimates, target were raised at Goldman Sachs. Shares now seen reaching $62. Estimates also increased on better than expected enrollment and revenue, Goldman said. Buy rating.

Apollo Group estimates changed through 2012 at UBS. Fourth-quarter new starts guidance was worse than expected, UBS said. Maintain Neutral rating and $42 price target.

Apollo Group price target raised to $47 at FBR Capital Markets. Company is making progress toward improving student outcomes, FBR said.

CareFusion (CFN - Get Report) estimates, target lowered at UBS. Shares now seen reaching $31. Estimates also lowered, on lower revenues from respiratory and dispensing, UBS said. Buy rating.

Colfax (CFX) price target was boosted to $30 at Bank of America/Merrill Lynch. Company is leveraged to a turn in the power generation cycle, BofA/Merrill said. Buy rating.

Cablevision (CVC - Get Report) estimates, target cut at Goldman Sachs. Shares now seen reaching $25. Estimates also lowered on slower growth, Goldman said. Neutral rating.

DeVry (DV) target raised at Citigroup. Price target increased to $64 on attractive fundamentals, diversified revenue mix and low regulatory exposure, Citigroup said. Maintain Buy rating.

Forest City (FCE) estimates changed through 2013 at Goldman Sachs. Near-term growth profile lags peers, Goldman said. Maintain Neutral rating and $18 price target.

First Solar (FSLR - Get Report) estimates, target raised at UBS. Shares now seen reaching $170. Estimates also increased, on substantial EPS visibility, UBS said. Buy rating.

Juniper (JNPR - Get Report) estimates, target cut at Barclays. Shares now seen reaching $47. Estimates also lowered on a switching dip and sluggish Japan, Barclays said. Overweight rating.

Lam Research (LRCX) numbers were cut through 2012 at Credit Suisse. Expect lower CapEx spending across the industry, Credit Suisse said. Outperform rating and new $60 price target.

Marathon Oil (MRO - Get Report) estimates, target cut at UBS. Shares now seen reaching $40. Estimates also lowered to reflect the completion of the downstream spin-off, UBS said. Buy rating.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs